Image

May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?

Recruiting
18 - 100 years of age
Both
Phase N/A

Powered by AI

Overview

The objective of our project is to find procedures and/or parameters to predict the diagnostic recovery (≥ 60% of the administered fluid volume) of bronchoalveolar lavage (BAL) fluid before bronchoscopy and to assess the impact of using non-invasive mechanical ventilation (NMV) or continuous positive airway pressure (CPAP) to achieve diagnostic recovery in patients with chronic obstructive pulmonary disease (COPD) and interstinal lungs disease for whom BAL performed during ordinary bronchoscopy turns out to be non-diagnostic.

Eligibility

Inclusion Criteria:

  1. Patients with diagnosed stable COPD (Stages 1-3) - experimental group; Patients with interstitial lung disease - experimental group
  2. Former and current smokers with normal lung function - potential control group 1;
  3. Never-smokers with normal lung ventilation - potential control group 2.

Exclusion Criteria:

  1. No written, informed consent to participate in the research project.
  2. Severe respiratory failure (SaO2 < 90%)
  3. The patient qualified for home oxygen treatment or home mechanical ventilation
  4. Severe heart failure (NYHA class IV)
  5. COPD mMRC IV
  6. Myocardial infarction in the last two weeks or unstable angina
  7. Severe, particularly ventricular arrhythmias
  8. Platelet count < 20,000/ul
  9. INR > 2 or APPT > 36 sec
  10. Very severe obstruction: forced expiratory volume in 1 second (FEV1) < 30% of predicted.

Study details

Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease

NCT05631132

Medical University of Silesia

28 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.